Home > Archive > 2008 >

Volume 27, Number 1 (March)

The Vytorin Controversy (pages 8-9)

Charles A. Reasner

Negative results from the ENHANCE trial and the delay in reporting the findings have caused to question the efficacy of ezetimibe and the integrity of the drug’s manufacturer. The Editor highlights the salient points of the results, the controversy they generated, and his own take on this.
Drug treatmentCholesterol-lowering drugs

Hyperinsulinemic Hypoglycemia Following Roux-en-Y Gastric Bypass Surgery (pages 10-18)

Irene Folaron, M.D., Capt., U.S.A.F., M.C., and Tom Sauerwein, M.D., Lt. Col., U.S.A.F., M.C.

Hyperinsulinemic hypoglycemia has recently emerged as a chronic complication of the Roux-en-Y bypass, the most common bariatric procedure in the United States. The authors offer a thorough and enlightening explanation of the possible mechanisms, as well as guidelines for diagnosis and treatment.
Surgery and hospital careBariatric surgery
Complications and comorbiditiesObesity

Point-of-Care Glycosylated Hemoglobin and Its Impact on Diabetes Care (pages 20-24)

Krisha S. Kasturi, M.B.B.S., M.P.H, and John R. Petersen, Ph.D., D.A.B.C.C., F.A.C.B.

The authors provide compelling evidence that point-of-care HbA1c results can verify the accuracy of home testing, provide a more accurate picture of glycemic control, allows timely decisions regarding changes in therapy, and thereby improve the management of diabetes.
Management strategies and toolsHbA1c testing
Management strategies and toolsStrategies for glycemic control

Alcohol Consumption and Diabetes (pages 27-30)

Allen B. King, M.D., C.D.E.

Moderate daily alcohol intake has been shown to have significant benefit to people with diabetes, but are there drawbacks? This article reviews the risks and benefits of moderate alcohol intake and recommendations that practitioners should make for their diabetic patients.
Diet therapy and nutrition
Management strategies and tools

Diagnosing and Managing Latent Autoimmune Diabetes in Adults (pages 32-37)

Jeff Unger, M.D.

People who present with clinical features of Type 2 diabetes may actually have latent autoimmune diabetes, a slowly progressive subtype of Type 1. Dr. Unger explains how to screen for this and how to treat to preserve beta-cell function and minimize long-term complications.
Latent autoimmune diabetes of adults